Annual results 2019 of CT market: ACTO report

Annual results 2019 of CT market: ACTO report
The Association of Clinical Trials Organizations (ACTO) (Russia) recently published an overview of clinical trials market in 2019. Overall, it noted positive trends in the market with a year on year increase of 14.2% in permits granted for clinical research.

Highlights from the report
In 2019, the Russian Ministry of Health issued 746 permits for clinical research (14.2% higher than in 2018). All types of research have shown an increase. There was an increase in studies initiated by international sponsors - 34.6% (it should be noted that this increase is based on low level 35 in 2019 v 26 in 2018). The report also noted a 19.2% increase in trials initiated by local sponsors (155 in 2019 v 130 in 2018). The number of permits for bioequivalence studies of foreign-made generics also grew (80 vs. 69) and Russian-made generics (163 vs. 141) increased by approximately the same percentage (15.9% and 15.6%). The number of permits for international multicenter clinical trials (ICI) increased by 9.1% to 313 compared to 287 in 2018.

 For more information, see the report:

 The report is available in Russian.

 Our team of experts is constantly monitoring and evaluating the latest developments in the clinical research to keep you up to date with market intelligence.

 To find out more about how COREX Logistics can support your business please email
Back to the list

Industry insights

Ethics committees

Ethics committee supervision is a vital part of all clinical trials.

Russia's first stem cell-based medica...

On March 12, the Russian Ministry of Health granted approval for clinical trials to test the efficacy of the country's first stem cell-based product for knee cartilage replacement.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.